Download FREE Report Sample
Download Free sampleNeuromuscular blocking drugs cause paralysis of the affected skeletal muscles by blocking neuromuscular transmission at the neuromuscular junction.
Neuromuscular Blocking Drug Market contains market size and forecasts of Neuromuscular Blocking Drug in global, including the following market information:
Global Neuromuscular Blocking Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Neuromuscular Blocking Drug Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Neuromuscular Blocking Drug companies in 2021 (%)
The global Neuromuscular Blocking Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Non-polarizing Agents Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Neuromuscular Blocking Drug include Hikma Pharmaceuticals, Merck, Novartis, Bayer, Pfizer, AbbVie and GSK, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Neuromuscular Blocking Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neuromuscular Blocking Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Neuromuscular Blocking Drug Market Segment Percentages, by Type, 2021 (%)
Non-polarizing Agents
Depolarizing Agents
Global Neuromuscular Blocking Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Neuromuscular Blocking Drug Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
Global Neuromuscular Blocking Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Neuromuscular Blocking Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neuromuscular Blocking Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Neuromuscular Blocking Drug revenues share in global market, 2021 (%)
Key companies Neuromuscular Blocking Drug sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Neuromuscular Blocking Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hikma Pharmaceuticals
Merck
Novartis
Bayer
Pfizer
AbbVie
GSK
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
